Cancer Comeback Crushed? Modena-Merck Twist

A personalized mRNA therapy paired with Keytruda cut melanoma’s return and spread in rigorous trials, and the effect kept holding up over years. Story Highlights Merck and Moderna reported lower melanoma recurrence with a custom mRNA therapy plus Keytruda. Follow-up showed sustained gains in recurrence-free and distant-metastasis-free survival. Five-year data point to about half the […]